Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Rectal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04072198
What this trial is testing

Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients

Who this might be right for
Colorectal Cancer
Gruppo Oncologico Italiano di Ricerca Clinica 73
Large-scale testing (Phase 3)Looking for participantsNCT07020247
What this trial is testing

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

Who this might be right for
Locally Advanced Rectal Cancer (LARC)ImmunotherapyRadiotherapy+2 more
West China Hospital 184
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06724263
What this trial is testing

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Recurrent Platinum-resistant Epithelial Ovarian CancerTriple Negative Breast Cancer (TNBC)Cervical Cancers+4 more
Tasly Biopharmaceuticals Co., Ltd. 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT03785249
What this trial is testing

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 731
Not applicableLooking for participantsNCT07225309
What this trial is testing

Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

Who this might be right for
Breast CancerProstate CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center 300
Testing effectiveness (Phase 2)Study completedNCT02723253
What this trial is testing

Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer

Who this might be right for
Rectal Neoplasms
IRCCS Azienda Ospedaliero-Universitaria di Bologna 18
Not applicableUnknownNCT05645094
What this trial is testing

Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaMSI-High
Fudan University 38
Testing effectiveness (Phase 2)Ended earlyNCT00602329
What this trial is testing

MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Abramson Cancer Center at Penn Medicine 5
Not applicableUnknownNCT04273477
What this trial is testing

Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Testing effectiveness (Phase 2)Ended earlyNCT05256381
What this trial is testing

SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more
SOTIO Biotech AG 166
Testing effectiveness (Phase 2)Study completedNCT02437656
What this trial is testing

Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer.

Who this might be right for
Rectal Cancer
Centre Oscar Lambret 60
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Testing effectiveness (Phase 2)UnknownNCT04838496
What this trial is testing

Induction Chemotherapy for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Catharina Ziekenhuis Eindhoven 128
Not applicableLooking for participantsNCT06193356
What this trial is testing

Detection of Endoscopic Resection Scars and Delineation of Recurrence is Trainable

Who this might be right for
Colorectal PolypColorectal Cancer
University Hospital, Ghent 141
Early research (Phase 1)Active Not RecruitingNCT06459869
What this trial is testing

NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Akamis Bio 30
Testing effectiveness (Phase 2)UnknownNCT00005877
What this trial is testing

Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
Astex Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT01576666
What this trial is testing

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Who this might be right for
Dose EscalationSafetyPreliminary Efficacy+9 more
Novartis Pharmaceuticals 120
Not applicableLooking for participantsNCT07776353
What this trial is testing

Understanding New Cachexia Subtypes Through Observational Epidemiological Research

Who this might be right for
Advanced Colorectal CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Pancreatic Adenocarcinoma+5 more
Kaiser Permanente 800
Not applicableStudy completedNCT07194954
What this trial is testing

Dietary Fiber and Probiotics in Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer (MSI-H)Malnutrition (Calorie)
The First Hospital of Hebei Medical University 80
Large-scale testing (Phase 3)Looking for participantsNCT06762405
What this trial is testing

PRODIGE 90 - (FFCD 2204) Neoadjuvant Dostarlimab with Short Course Radiotherapy in a Watch-and-wait Strategy for Microsatellite Unstable or Mismatch Repair-deficient Locally Advanced Rectal Cancer Patients

Who this might be right for
Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)
Centre Hospitalier Universitaire Dijon 68
Next Page